☆ 4.7 Editorial Material

Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer

JOURNAL OF CLINICAL ONCOLOGY (2016)

期刊

JOURNAL OF CLINICAL ONCOLOGY

卷 34, 期 16, 页码 E151-E155

出版社

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2012.44.8894

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+breast cancer leptomeningeal metastases

Anna-Maria Lazaratos, Sarah M. Maritan, Andrea Quaiattini, Amelie Darlix, Ivica Ratosa, Emanuela Ferraro, Gaia Griguolo, Valentina Guarneri, Alessia Pellerino, Silvia Hofer, William Jacot, Hans-Joachim Stemmler, Marcel P. H. van den Broek, Nika Dobnikar, Francois Panet, Zubin Lahijanian, Aki Morikawa, Andrew D. Seidman, Riccardo Soffietti, Lawrence Panasci, Kevin Petrecca, April A. N. Rose, Nathaniel Bouganim, Matthew Dankner

Summary: Intrathecal administration of HER2-targeted therapy does not provide additional benefits for HER2+ breast cancer patients with leptomeningeal metastases compared to oral or intravenous treatment regimens. However, treatment with trastuzumab-deruxtecan may lead to prolonged overall survival for these patients, but further research is needed to confirm this.

BREAST (2023)

添加到收藏夹

Article Oncology

Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases

Sanja Loeb, Eva Linsmeier, Saskia-Laureen Herbert, Tanja Schlaiss, Matthias Kiesel, Joerg Wischhusen, Jessica Salmen, Peter Kranke, Anne Quenzer, Florian Kurz, Claire Weiss, Elena Gerhard-Hartmann, Achim Woeckel, Joachim Diessner

Summary: The purpose of this study was to investigate the changes in HER2 subtypes between primary breast cancer and recurrent disease. The results showed that HER2 expression increased during the progression of the disease. This information is important for the development of therapeutic options for breast cancer patients.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Review Oncology

Current treatment options for HER2-positive breast cancer patients with brain metastases

Daniele Galanti, Alessandro Inno, Maria La Vecchia, Nicolo Borsellino, Lorena Incorvaia, Antonio Russo, Stefania Gori

Summary: Brain metastases are often associated with HER2+ breast cancer, and systemic therapy with trastuzumab has been the mainstay. Other HER2-targeted agents have been introduced in clinical practice, with newer agents such as neratinib, tucatinib, and trastuzumab deruxtecan showing interesting activity against brain metastases. Further research is needed to elucidate the optimal sequence of these agents and their combination with local treatment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

添加到收藏夹

Article Oncology

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis

Guy Jerusalem, Yeon Hee Park, Toshinari Yamashita, Sara A. Hurvitz, Shanu Modi, Fabrice Andre, Ian E. Krop, Xavier Gonzalez Farre, Benoit You, Cristina Saura, Sung-Bae Kim, Cynthia R. Osborne, Rashmi K. Murthy, Lorenzo Gianni, Toshimi Takano, Yali Liu, Jillian Cathcart, Caleb Lee, Christophe Perrin

Summary: The DESTINY-Breast01 study evaluated the efficacy of trastuzumab deruxtecan in heavily pretreated HER2-positive metastatic breast cancer patients, and found that it showed durable clinical activity in patients with treated brain metastases.

CANCER DISCOVERY (2022)

添加到收藏夹

Review Cell Biology

Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy

Qitong Wu, Dipali Sharma

Summary: Despite the improvement in the prognosis of breast cancer due to targeted therapies and novel combination regimens, the development of drug resistance or reduced efficacy poses a challenge. Cancer cells activate autophagy to adapt and evade most therapies, hindering treatment effectiveness. This review discusses the role of autophagy and its associated proteins in breast cancer growth, drug sensitivity, tumor dormancy, stemness, and recurrence. The modulation of various intermediate proteins, miRs, and lncRNAs by autophagy also reduces the efficacy of endocrine therapies, targeted therapies, radiotherapy, chemotherapies, and immunotherapy.

CELLS (2023)

添加到收藏夹

Article Oncology

Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer

Erwin Tomasich, Ariane Steindl, Christina Paiato, Teresa Hatziioannou, Markus Kleinberger, Luzia Berchtold, Rainer Puhr, Johannes A. Hainfellner, Leonhard Mullauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna Sophie Berghoff

Summary: This study investigated the expression of HER3 in brain metastases of breast cancer and non-small cell lung cancer, providing a basis for future clinical trial design. Results showed that HER3 is highly expressed in brain metastases of both cancer types, suggesting the need for specific trials targeting HER3 in brain metastases.

CLINICAL CANCER RESEARCH (2023)

添加到收藏夹

Article Oncology

Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis

Florence Oberkampf, Maya Gutierrez, Olfa Trabelsi Grati, Emilie Le Rhun, Olivier Tredan, Isabelle Turbiez, Amir Kadi, Coraline Dubot, Sophie Taillibert, Sophie Vacher, Claire Bonneau

Summary: This study aimed to evaluate the efficacy of intrathecal trastuzumab in HER2 + BC patients with leptomeningeal metastasis. The results showed that weekly administration of 150 mg of intrathecal trastuzumab was effective in controlling neurological progression.

NEURO-ONCOLOGY (2023)

添加到收藏夹

Review Oncology

Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies

Alejandro Garcia-Alvarez, Andri Papakonstantinou, Mafalda Oliveira

Summary: Development of brain metastases is a significant event for patients with breast cancer, particularly those with HER2-positive tumors. Advances in targeted therapy against the HER2 receptor have improved management of HER2-positive breast cancer. Despite these improvements, brain metastases continue to be a challenge, highlighting the need for further research and innovative treatment strategies.

CANCERS (2021)

添加到收藏夹

Review Oncology

Treatment strategies for breast cancer brain metastases

Caroline Bailleux, Lauriane Eberst, Thomas Bachelot

Summary: Brain metastases from breast cancer are becoming more common and represent a major therapeutic challenge. Surgery and stereotaxic radiosurgery are effective for controlling BCBM.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer

Oana Gabriela Trifanescu, Dan Mitrea, Laurentia Nicoleta Gales, Ana Ciornei, Mihai-Andrei Paun, Ioana Butnariu, Raluca Alexandra Trifanescu, Natalia Motas, Radu Valeriu Toma, Liviu Bilteanu, Mirela Gherghe, Rodica Maricela Anghel

Summary: This pilot study evaluated the efficacy of intrathecal Trastuzumab as a local treatment for leptomeningeal metastases in patients with HER2-positive breast cancer. Results showed that intrathecal Trastuzumab combined with standard of care treatment had a good response rate, with some patients experiencing durable responses lasting more than 12 months.

CANCERS (2023)

添加到收藏夹

Review Oncology

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis

Inge M. Werter, Sharon Remmelzwaal, George L. Burchell, Tanja D. de Gruijl, Inge R. Konings, Hans J. van der Vliet, C. Willemien Menke-van der Houven Van Oordt

Summary: This study aimed to investigate the impact of different systemic therapies on patients with HER2-positive metastatic breast cancer and brain metastases. The most effective treatments appeared to be Tucatinib and trastuzumab-deruxtecan, while pyrotinib might be suitable for Asian patients.

CANCERS (2022)

添加到收藏夹

Article Oncology

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+breast cancer brain metastases

Matthew N. Mills, Chelsea Walker, Chetna Thawani, Afrin Naz, Nicholas B. Figura, Sergiy Kushchayev, Arnold Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed

Summary: The combination treatment of stereotactic radiation and T-DM1 is well-tolerated and effective for patients with HER2-positive breast cancer brain metastases. There was no increased risk noted for symptomatic radiation necrosis in this study.

BMC CANCER (2021)

添加到收藏夹

Article Medicine, General & Internal

Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases

Xiaoping Ma, Yan Li, Li Li, Chunyan Gao, Dan Liu, Hongyu Li, Zhenhui Zhao, Bing Zhao

Summary: The study explored effective methods through combining pyrotinib to treat brain metastasis with HER2-positive advanced breast cancer. Pyrotinib-based combination therapy was found to be safe and efficient for treating HER2-positive brain metastasis, with pyrotinib combined with nab-paclitaxel showing superior efficacy.

ANNALS OF MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases

Maya Kaduri, Mor Sela, Shaked Kagan, Maria Poley, Hanan Abumanhal-Masarweh, Patricia Mora-Raimundo, Alberto Ouro, Nitsan Dahan, Dov Hershkovitz, Jeny Shklover, Janna Shainsky-Roitman, Yosef Buganim, Avi Schroeder

Summary: Neurons within the tumor microenvironment play a role in promoting cancer progression, making local targeting of neurons potentially beneficial in clinical applications. Utilizing PEGylated lipid nanoparticles loaded with bupivacaine, researchers were able to suppress nerve-to-cancer cross-talk and inhibit cancer cell viability by curbing neurite growth and signaling in breast cancer tumors. The findings suggest that reducing nerve involvement in tumors is crucial for effective cancer treatment.

SCIENCE ADVANCES (2021)

添加到收藏夹

Article Oncology

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

M. Carausu, M. Carton, A. Darlix, D. Pasquier, M. Leheurteur, M. Debled, M. A. Mouret-Reynier, A. Goncalves, F. Dalenc, B. Verret, M. Campone, P. Augereau, J. M. Ferrero, C. Levy, J-D Fumet, C. Lefeuvre-Plesse, T. Petit, L. Uwer, C. Jouannaud, L. Larrouquere, M. Chevrot, C. Courtinard, L. Cabel

Summary: Leptomeningeal metastasis is a rare and dangerous complication of metastatic breast cancer. Patients treated with intrathecal therapy usually have poor prognosis, but a subgroup of patients may have better outcomes when concomitant systemic therapy and methotrexate are used.

ESMO OPEN (2021)

添加到收藏夹

Article Biochemical Research Methods

A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations

Celine Desvignes, David Ternant, Thierry Lecomte, Astrid Lievre, Marc Ohresser, Romain Chautard, William Raoul, Gilles Paintaud

Summary: An ELISA assay measuring ramucirumab serum concentrations was developed and validated, suitable for pharmacokinetic studies of ramucirumab with good sensitivity, accuracy, reproducibility.

BIOANALYSIS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells

Romain Chautard, Laetitia Corset, Sajida Ibrahim, Celine Desvignes, Gilles Paintaud, Nadine Baroukh, Maxime Gueguinou, Thierry Lecomte, William Raoul

Summary: The study found significant effects of cetuximab and panitumumab exposure on miR expression in colorectal cancer cells, with some miR interacting with downstream elements of the EGFR pathway. 5 miRs rarely described before were identified as potential actors of anti-EGFR monoclonal antibody resistance, and miR-139-5p and miR-145-5p were detected in the serum of patients with metastatic CRC.

BIOMARKERS IN MEDICINE (2021)

添加到收藏夹

Review Urology & Nephrology

Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Thi Oanh Bui, Van Tu Dao, Van Tai Nguyen, Jean-Paul Feugeas, Frederic Pamoukdjian, Guilhem Bousquet

Summary: Genetic tumor heterogeneity is a major cause of resistance in metastatic renal cell carcinoma patients. A meta-analysis of genomic data from 14,696 patients revealed a higher level of mutations in metastases compared to primary tumors, emphasizing the importance of biopsies on metastases in guiding treatment strategies.

EUROPEAN UROLOGY (2022)

添加到收藏夹

Review Oncology

Dose-Intense Cisplatin-Based Neoadjuvant Chemotherapy Increases Survival in Advanced Cervical Cancer: An Up-to-Date Meta-Analysis

Van Tai Nguyen, Sabine Winterman, Margot Playe, Amelie Benbara, Laurent Zelek, Frederic Pamoukdjian, Guilhem Bousquet

Summary: This article used a meta-analysis to study the effectiveness of dose-intense cisplatin-based neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. The results showed that this treatment could improve overall survival and open up new possibilities for clinical trials in cases where local treatment is suboptimal.

CANCERS (2022)

添加到收藏夹

Article Oncology

The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery

Philippe Wind, Zoe ap Thomas, Marie Laurent, Thomas Aparicio, Matthieu Siebert, Etienne Audureau, Elena Paillaud, Guilhem Bousquet, Frederic Pamoukdjian

Summary: The pre-operative GRADE score, which combines simple geriatric and cancer parameters, can provide a prognosis and help surgeons choose the most suitable treatment strategy for older cancer patients undergoing major surgery for digestive or non-breast gynaecological cancers, thereby avoiding under or over-treatment.

CANCERS (2022)

添加到收藏夹

Article Health Care Sciences & Services

A Teleconsultation Device, Consult Station, for Remote Primary Care: Multisite Prospective Cohort Study

Geraldine Falgarone, Guilhem Bousquet, Arnaud Wilmet, Albert Brizio, Valerie Faure, Celestin Guillouet, Franck Baudino, Isabelle Roque, Samuel Mayol, Frederic Pamoukjian

Summary: This study examined the implementation of the telemedicine device Consult Station in areas with a low density of medical services and evaluated its contribution to health care pathways. The results showed that Consult Station was mainly used by younger women for low-severity seasonal infections, while consultations for hypertension, diabetes, and preventive medicine were less common. The implementation of Consult Station could address the challenge of medical deserts and potentially reduce work absenteeism.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

添加到收藏夹

Editorial Material Rheumatology

Pyrogenic lower limbs

Eurydice Angeli, Alexander Ariel Padron Gonzalez, Diaddin Hamdan, Gabriel Pop, Geraldine Falgarone, Guilhem Bousquet

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Letter Infectious Diseases

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

Xavier de Lamballerie, Guillaume Martin-Blondel, Axelle Dupont, Jacques Izopet, France Mentre, Nassim Kamar, Brigitte Autran, Gilles Paintaud, Sophie Caillard, Amandine le Bourgeois, Christophe Richez, Lionel Couzi, Alienor Xhaard, Zora Marjanovic, Jerome Avouac, Caroline Jacquet, Denis Anglicheau, Morgane Cheminant, Yazdan Yazdanpanah, Stephanie N. Guyen, Benjamin Terrier, Jacques Eric Gottenberg, Caroline Besson, Sophie Letrou, Sabrina Kali, Denis Angoulvant, Ventzislava Petrov Sanchez, Coralie Tardivon, Gilles Blancho, Vincent Levy

JOURNAL OF INFECTION (2023)

添加到收藏夹

Correction Health Care Sciences & Services

Teleconsultation Device, Consult Station, for Remote Primary Care: Multisite Prospective Cohort Study (vol 24, e43220, 2022)

Geraldine Falgarone, Guilhem Bousquet, Arnaud Wilmet, Albert Brizio, Valerie Faure, Celestin Guillouet, Franck Baudino, Isabelle Roque, Samuel Mayol, Frederic Pamoukdjian

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A massive open online course to teach undergraduate medical students in oncology: keys of success

Diaddin Hamdan, Frederic Pamoukdjian, Jaqueline Lehmann-Che, Cedric de Bazelaire, Laetitia Vercellino, Julien Calvani, Maxime Battistella, Philippe Bertheau, Geraldine Falgarone, Guilhem Bousquet

Summary: Massive Open Online Courses (MOOCs), which have gained popularity in education, were evaluated in this study to determine their impact on undergraduate medical students. The study focused on a MOOC for oncology teaching and found that it had a positive effect on students' grades. The students' socioeconomic status and willingness to participate were significantly associated with their final results.

HELIYON (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review

Burak Gonullu, Eurydice Angeli, Frederic Pamoukdjian, Guilhem Bousquet

Summary: Anti-HER2 therapies greatly improve the prognosis of HER2-overexpressing cancers, but the relationship between HER2 copy number and response rate to treatment is unclear. A meta-analysis was performed on 9 studies, involving 11,238 women with breast cancer, to study the association between HER2 amplification level and pathological complete response (pCR). The analysis showed that higher HER2/CEP17 ratio was associated with higher pCR rates, confirming the potential therapeutic value of considering HER2 amplification level.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Surgery

Ultrasound assessment is linked to histological vein wall thickness in chronic venous disease

Sammi Zerrouk, Paolo Casoni, Edoardo Cervi, Rafik Amirat, Guilhem Bousquet, Christophe Leboeuf, Anne Janin, Frederic Pamoukdjian

Summary: This study aimed to compare ultrasound and histological approaches for patients with chronic venous disease (CVD). The results showed that ultrasound assessment of vein wall thickness (VWT) could be a non-invasive tool for diagnosis and follow-up in CVD, and could help optimize treatment plans.

PHLEBOLOGY (2023)

添加到收藏夹

Article Oncology

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications

Thuy Thi Nguyen, Diaddin Hamdan, Eurydice Angeli, Jean-Paul Feugeas, Quang Van Le, Frederic Pamoukdjian, Guilhem Bousquet

Summary: Breast cancer brain metastases are a challenging daily practice. This study performed a meta-analysis on genomic data to identify gene alterations associated with metastatic processes in the brain. Six genes with a higher mutation prevalence in brain metastases than in extracerebral metastases were identified, indicating their potential therapeutic implications.

CANCERS (2023)

添加到收藏夹

Editorial Material Oncology

A Boom in Nanotechnologies for a High Level of Precision Medicine

Eurydice Angeli, Guilhem Bousquet

CANCERS (2023)

添加到收藏夹

Letter Oncology

Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment

Thi Oanh Bui, Eurydice Angeli, Morad El Bouchtaoui, Guillaume Gapihan, Van Tu Dao, Justine Paris, Christophe Leboeuf, Michael Soussan, Patrick Villarese, Marianne Ziol, Emmanuel Van Glabeke, Thi Huong Le, Jean-Paul Feugeas, Anne Janin, Guilhem Bousquet

Summary: This study identified a frequent pL1575P NOTCH1 mutation as a new biomarker for ccRCC metastases and predictive of response to the CB103 NOTCH1-intracellular domain inhibitor.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.